NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine ...

Researchers develop quinoline-based drug with inhibitory activity against the SARS-CoV-2 papain-like protease (PLpro).

World Health Organization members are finalizing plans for nations to share life-saving technology with developing countries ...

The Michigan Court of Appeals, in effect, ruled that Chelsea Hospital and the drugmaker, Gilead Sciences Inc., are immune ...

Low vaccination rates for influenza viruses and the lack of an HSV vaccine underscore the need for a new approach to reduce viral transmission. Researchers have now used a clinical-grade antiviral ...

Scientists say a new AI method for looking at cells could speed up drug development by six years ... large outbreaks of Ebola virus have had major impacts globally, including socioeconomic ...

The comments mirror those made by DOGE’s de facto leader, Elon Musk, who said in February the effort had “accidentally canceled” the U.S. Agency for International Development (USAID)’s program to ...

Scientists develop an antiviral chewing gum that neutralizes over 95% of influenza and herpes viruses, potentially ...